Goldline Pharmaceutical Peer Comparison
BSE: 544759
₹40.00
₹-0.97
(-2.37%)
As on 31-Aug-2026IST
Market cap
₹38 Cr
Revenue (TTM)
₹31 Cr
P/E Ratio
9.3
P/B Ratio
1.6
Div. Yield
0 %
Edit
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
38 | 7,860 | 32 | 30 | 20 |
Revenue (₹ Cr) |
31 | 7,128 | 13 | 366 | -3 |
Net Profit (₹ Cr) |
4.12 | 167.66 | -1.78 | -16.99 | -0.07 |
Net Margin (%) |
13.20 | 2.35 | -8.71 | -4.63 | 2.62 |
RoE (%) |
39.41 | 7.58 | -1.56 | -14.35 | -0.66 |
Price to Earnings |
9.33 | 62.68 | -- | -- | -- |
Price-To-Book |
1.60 | 4.53 | 0.29 | 0.31 | 1.99 |
Income Statement (₹ Cr)
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Operating Revenue
|
31.20 | 6,591.21 | 12.45 | -- | -- |
|
Total Income
|
31.20 | 6,610.45 | 20.66 | -- | -- |
|
Total Expenditure
|
24.12 | 6,325.26 | 21.85 | -- | -- |
|
EBITDA
|
7.08 | 265.96 | -9.40 | -- | -- |
|
Depreciation
|
0.24 | 43.29 | 1.81 | -- | -- |
|
EBIT
|
6.84 | 222.66 | -11.21 | -- | -- |
|
Interest
|
1.46 | 54.39 | 0.02 | -- | -- |
|
Other Income
|
0.00 | 19.24 | 8.21 | -- | -- |
|
Exceptional Items
|
-- | -8.18 | -- | -- | -- |
|
Profit before Tax
|
5.39 | 179.34 | -3.02 | -- | -- |
|
Provision for Tax
|
1.27 | 33.50 | 0.01 | -- | -- |
|
Profit after Tax
|
4.12 | 145.84 | -3.04 | -- | -- |
Liabilities (₹ Cr)
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
14.25 | 1,688.61 | 111.61 | -- | -- |
|
Minority Interest
|
-- | 63.94 | -- | -- | -- |
|
Non-Current Liabilities
|
2.43 | 206.12 | 1.14 | -- | -- |
|
Current Liabilities
|
12.11 | 1,587.57 | 2.71 | -- | -- |
|
Total Liabilities
|
28.87 | 3,600.22 | 115.46 | -- | -- |
Assets (₹ Cr)
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2.75 | 1,037.80 | 68.44 | -- | -- |
|
Current Assets
|
26.05 | 2,503.13 | 47.02 | -- | -- |
|
Total Assets
|
28.87 | 3,600.22 | 115.46 | -- | -- |
|
Total Debt*
|
9.16 | 566.68 | 0.00 | -- | -- |
|
Net Current Assets
|
13.93 | 915.56 | 44.31 | -- | -- |
|
Contingent Liabilities
|
3.37 | 5.51 | -- | -- | -- |
Cashflow (₹ Cr)
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
2.81 | 96.20 | -7.02 | -- | -- |
|
Cash Flow from Investing Activities
|
-0.06 | -303.06 | 7.11 | -- | -- |
|
Cash from Financing Activities
|
-3.40 | 123.66 | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-0.65 | -83.20 | 0.09 | -- | -- |
Ratios
Profitability Ratios
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
ROCE (%)
|
30.60 | 10.93 | -2.58 | -- | -- |
|
ROE (%)
|
39.41 | 8.57 | -2.61 | -- | -- |
|
ROA (%)
|
14.98 | 4.68 | -2.52 | -- | -- |
|
EBIT Margin (%)
|
22.70 | 4.33 | -9.59 | -- | -- |
|
Net Margin (%)
|
13.20 | 2.21 | -14.70 | -- | -- |
|
Cash Profit Margin (%)
|
13.97 | 2.87 | -9.88 | -- | -- |
Growth Ratios
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.20 | 29.35 | -51.14 | -- | -- |
|
EBIT Growth (%)
|
16.95 | 35.13 | -229.03 | -- | -- |
|
Net Profit Growth (%)
|
45.26 | 35.75 | -431.96 | -- | -- |
|
EPS Growth (%)
|
45.26 | 21.32 | -431.95 | -- | -- |
|
Book Value Growth (%)
|
47.19 | -2.19 | -7.97 | -- | -- |
Valuation Ratios
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 47.12 | 0.00 | -- | -- |
|
Price / Book Value
|
0.00 | 3.22 | 0.26 | -- | -- |
|
Dividend Yield (%)
|
-- | 0.00 | 0.00 | -- | -- |
|
EV/EBITDA
|
2.44 | 20.43 | -23.82 | -- | -- |
|
Market Cap (₹ Cr)
|
0.00 | 5,420.61 | 28.93 | -- | -- |
Solvency Ratios
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.64 | 0.34 | 0.00 | -- | -- |
|
Short term debt to equity ratio
|
0.42 | 0.26 | -- | -- | -- |
|
Current Ratio
|
2.15 | 1.58 | 17.34 | -- | -- |
|
Quick Ratio
|
1.64 | 1.05 | 16.26 | -- | -- |
|
Interest Coverage
|
4.70 | 4.30 | -137.05 | -- | -- |
Operating Efficiency Ratios
| Goldline Pharmaceutical | Entero Health | Medi-Caps | Welcure Drugs | Pentokey Organy | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
51.70 | 18.39 | 55.60 | -- | -- |
|
Asset Turnover
|
1.13 | 2.11 | 0.10 | -- | -- |
|
Receivable days
|
156.90 | 56.56 | 230.34 | -- | -- |
|
Inventory Days
|
75.99 | 41.57 | 90.05 | -- | -- |
|
Payable days
|
64.86 | 34.66 | 71.74 | -- | -- |
|
Cash Conversion Cycle
|
168.03 | 63.47 | 248.65 | -- | -- |
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
